Innovative Home Care Models and Medication Cost Challenges Shape Sweden's Healthcare Accessibility

Sweden is witnessing key developments aimed at enhancing healthcare accessibility for its population, focusing both on innovative care delivery and addressing rising medication costs. At a recent gathering, around 100 attendees heard from nurses Maria Rännare and Marie Huhtanen about a new care method called "Nära tillgänglig vård" (Close Accessible Care). This initiative, pioneered at Övertorneå Health Center, centers on delivering care at home for individuals who need healthcare but neither qualify for home healthcare nor can physically visit health centers. By collaborating closely with municipalities, the program strengthens holistic health, care, and home support services, aiming to ensure that patients receive equitable, coordinated, and needs-based care, in line with the 2020 Swedish parliamentary reform positioning primary care as the core of healthcare.

Concurrently, Sweden faces challenges in medication affordability for chronic disease patients, particularly those living with diabetes. Over 600,000 people nationwide, including more than 20,000 in Region Uppsala, depend on multiple medications to manage their condition and prevent complications such as cardiovascular disease and kidney damage. However, rising costs threaten adherence; the Diabetes Barometer 2026 found that 8% of respondents had either skipped medications or borrowed money to cover costs, with women disproportionately affected and nearly 60% of those skipping medication reporting negative health outcomes. These economic pressures jeopardize Sweden’s principle that healthcare should be determined by need rather than financial ability. Advocates warn that a weakened high-cost protection scheme risks increased hospitalizations and greater long-term healthcare expenses.

The healthcare innovations and challenges thus highlight the ongoing need for policies that foster equitable access and sustainable care. As the new government forms, stakeholders urge strengthening protections to ensure life-saving medications remain affordable, safeguarding both patient welfare and the healthcare system’s integrity.